Inducible cyclooxygenase may have anti-inflammatory properties (original) (raw)

Nature Medicine volume 5, pages 698–701 (1999)Cite this article

Abstract

Cyclooxygenase (COX) has two isoforms. Generally, COX 1 is constitutively expressed in most tissues, where it maintains physiological processes1; inducible COX 2 is considered a pro-inflammatory enzyme and a chief target for the treatment of inflammatory diseases2. Here we present evidence that COX 2 may have anti-inflammatory properties. In carrageenin-induced pleurisy in rats, the predominant cells at 2 hours are polymorphonuclear leucocytes, whereas mononuclear cells dominate from 24 hours until resolution at 48 hours3. In this model, COX 2 protein expression peaked initially at 2 hours, associated with maximal prostaglandin E2 synthesis. However, at 48 hours there was a second increase in COX 2 expression, 350% greater than that at 2 hours. Paradoxically, this coincided with inflammatory resolution and was associated with minimal prostaglandin E2 synthesis. In contrast, levels of prostaglandin D2, and 15deoxyΔ12,13,14prostaglandin J2 were high at 2 hours, decreased as inflammation increased, but were increased again at 48 hours. The selective COX 2 inhibitor NS-398 and the dual COX 1/COX 2 inhibitor indomethacin inhibited inflammation at 2 hours but significantly exacerbated inflammation at 48 hours. This exacerbation was associated with reduced exudate prostaglandin D2 and 15deoxyΔ12,13,14prostaglandin J2 concentrations, and was reversed by replacement of these prostaglandins. Thus, COX 2 may be pro-inflammatory during the early phase of a carrageenin-induced pleurisy, dominated by polymorphonuclear leucocytes, but may aid resolution at the later, mononuclear cell-dominated phase by generating an alternative set of anti-inflammatory prostaglandins.

This is a preview of subscription content, access via your institution

Access options

Subscribe to this journal

Receive 12 print issues and online access

$209.00 per year

only $17.42 per issue

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Additional access options:

Similar content being viewed by others

References

  1. DeWitt, D.L. Prostaglandin endoperoxide synthase: regulation of enzyme expression. Biochim. Biophys. Acta 1083, 121–134 (1991).
    Article CAS Google Scholar
  2. Vane, J.R. Towards a better aspirin. Nature 367, 215 –216 (1994).
    Article CAS Google Scholar
  3. Tomlinson, A. et al. Cyclooxygenase and nitric oxide synthase isoforms in rat carrageenin- induced pleurisy. Br. J. Pharmacol. 113 , 693–698 (1994).
    Article CAS Google Scholar
  4. Willis, D., Moore, A.R., Frederick, R., Willoughby, D.A. & Heme Oxygenase: A novel target for the modulation of the inflammatory response. Nature Med. 2, 87 –90 (1996).
    Article CAS Google Scholar
  5. Futaki, N. et al. NS-398, a new antiinflammatory agent, selectively inhibits prsotaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47, 55– 59 (1994).
    Article CAS Google Scholar
  6. Mitchell, J.A., Akarasereenont, P., Thiemermann, C., Flowers, R.J. & Vane, J.R. Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc. Natl. Acad. Sci. USA 90, 11693– 11697 (1993).
    Article CAS Google Scholar
  7. Masferrer, J.L. et al. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA 91, 3228–32 ( 1994).
    Article CAS Google Scholar
  8. Masso, J.M., Villar, A.M., Conde, J.R. & Martorell, J. Effects of fepradinol on rat acute models of vascular permeability and leucocyte migration. Agents Actions 42, 118– 22 (1994).
    Article CAS Google Scholar
  9. Williams, K.I. & Higgs, G.A. Eicosanoids and inflammation. J. Pathol. 156, 101–110 (1988).
    Article CAS Google Scholar
  10. Ricote, M., Li, A.C., Willson, T.M., Kelly, C.J. & Glass, C.K. The peroxisome proliferator- activated receptor-gamma is a negative regulator of macrophage activation. Nature 391, 79–82 (1998).
    Article CAS Google Scholar
  11. Spencer, A.G., Woods, J.W. Arakawa, J.W., Singer, I.I. & Smith, W.L. Subcellular localisation of prostaglandin endoperoxide H synthase-1 and -2 by immunoelectron microscopy. J. Biol. Chem. 273, 9886–9893 (1998).
    Article CAS Google Scholar
  12. Ujihara, M. et al. Prostaglandin D2 formation and characterisation of its synthetases in various tissues of adult rats. Arch. Biochem. Biophys. 260, 521–531 ( 1988).
    Article CAS Google Scholar
  13. Fournier, T., Fadok, V., Henson, P.M. Tumor necrosis factor-α inversely regulates prostaglandin D2 and prostaglandin E2 production in murine macrophages. J. Biol. Chem. 272, 31065–31072 (1997).
    Article CAS Google Scholar
  14. Mizuno, H. et al. Induction of cyclooxygenase 2 in gastric mucosal lesions and its inhibition by the specific antagonist delays healing in mice. Gastroenterology 112, 387–397 (1997).
    Article CAS Google Scholar
  15. Schmassmann, A. et al. Effects of inhibition of prostaglandin endoperoxide synthase 2 in gastric intestinal models in rats. Br. J. Pharmacol. 123, 795–805 (1998).
    Article CAS Google Scholar
  16. Shigeta J., Takashi, S., Okabe, S. Role of cyclooxygenase 2 in the healing of gastric ulcers in rats. J. Pharmacol. Exp. Therap. 286, 1383– 1390 (1998).
    CAS Google Scholar
  17. Medical Research Council and Nuffield Foundation Joint Committee. Ann. Rheumatic Dis. 18, 173– 188 (1959).
  18. Gilroy, D., Tomlinson, A., Greenslade, K., Seed, M.P. & Willoughby, D.A. The effects of cyclooxygenase 2 inhibitors on cartilage erosion and bone loss in a model of mycobacterium tuberculosis-induced monoarticular arthritis in the rat. Inflammation 22, 509–519 ( 1998).
    Article CAS Google Scholar
  19. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248–54 ( 1976).
    Article CAS Google Scholar

Download references

Acknowledgements

The authors acknowledge the support of the following organizations: D.W.G., The Hyal Research Foundation, Canada; P.R.C.-N., The Joint Research Board of the Special Trustees of St. Bartholomew's Hosptial, London, UK and the Arthritis Research Campaign, UK; D.W., Oliver Bird Fund, Nuffield Foundation, UK.

Author information

Authors and Affiliations

  1. Department of Experimental Pathology, St. Bartholomew's & Royal London School of Medicine and Dentistry, London, EC1M 6BQ, UK
    Derek W. Gilroy, P.R. Colville-Nash, D. Willis, J. Chivers, M.J. Paul-Clark & D.A. Willoughby

Authors

  1. Derek W. Gilroy
    You can also search for this author inPubMed Google Scholar
  2. P.R. Colville-Nash
    You can also search for this author inPubMed Google Scholar
  3. D. Willis
    You can also search for this author inPubMed Google Scholar
  4. J. Chivers
    You can also search for this author inPubMed Google Scholar
  5. M.J. Paul-Clark
    You can also search for this author inPubMed Google Scholar
  6. D.A. Willoughby
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toP.R. Colville-Nash.

Rights and permissions

About this article

Cite this article

Gilroy, D., Colville-Nash, P., Willis, D. et al. Inducible cyclooxygenase may have anti-inflammatory properties.Nat Med 5, 698–701 (1999). https://doi.org/10.1038/9550

Download citation